Animal Antibiotics and Antimicrobials Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Animal Antibiotics and Antimicrobials Market: By Product Type (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins and Other Antimicrobials and Antibiotics), By Mode of Delivery (Premixes, Oral Powder, Oral Solution, Injection and Others)By Animal Type (Food-Producing Animals, Companion Animals), and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Categories: Animal Healthcare, Veterinary

Description
Table Of Content
Company Profile

Report

Description

Animal Antibiotics and Antimicrobials Market size was valued at USD 4,561.3 million in 2021. It is expected to reach a value of USD 6,083.6 million by 2028, growing at a CAGR of 4.2% from 2022 to 2028. The global market provides a detailed overview of the animal antibiotics and antimicrobials market, which can be segmented by product type, mode of delivery, and animal type. By product type, the animal antibiotics and antimicrobials market has been segmented into tetracyclines, penicillin, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. The penicillins segment is likely to be the largest and fastest-growing segment in terms of product type. Based on mode of delivery, the animal antibiotics and antimicrobials market is segmented into premixes, oral powder, oral solution, injection, and others. Among these, the premixes segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on animal type, the market is segregated into food-producing animals and companion animals. The food-producing animal segment held a considerable market share during the forecast period.

Key Developments:

In Jul 2020, Zoetis collaborated with Trianni, Inc to build transgenic monoclonal antibody platforms to develop novel veterinary therapeutics.

Animal Antibiotics and Antimicrobials Market

MARKET SUMMARY

4.2%

Study Period– 2022-2028
Base Year– 2021
CAGR– 4.2%
Largest Market– Asia Pacific
Fastest Growing Market– North America

Animal Antibiotics and Antimicrobials Market

The report on global animal antibiotics and antimicrobials market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, by mode of delivery, by animal type and geography.
The global animal antibiotics and antimicrobials market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa

Key Players

Phibro Animal Health (US)
Vetoquinol S.A. (France)
Ceva Santé Animale (France)
Dechra Pharmaceuticals Plc (UK)
Kyoritsu Seiyaku (Japan)

Animal Antibiotics and Antimicrobials Market Drivers

Pet insurance increases primarily due to the increased cost of veterinarian services and treatments, increased demand for cattle-related items, and growth due to increased public awareness of various animal diseases are some key factors fostering the market growth.

North-America Got Significant Share

Animal Antibiotics and Antimicrobials Market

The North American market is expected to witness the highest market share during the forecast period. This region's substantial contribution is mainly related to its expanding animal population, rising demand for animal-based commodities, development of pet insurance, and spending higher than average costs for animal health care. The Asia-Pacific market expanded significantly during the anticipated period. The demand for animal antimicrobials has increased, and there are more animals, all of which are contributing reasons to the expansion of this industry.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The animal antibiotics and antimicrobials market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
The animal antibiotics and antimicrobials market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The animal antibiotics and antimicrobials market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The animal antibiotics and antimicrobials market report tracks recent innovations, key developments, and start-up details that are actively working in the market
The animal antibiotics and antimicrobials market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Animal Antibiotics and Antimicrobials Market Segmentation

By Product Type

Tetracyclines,
Penicillins,
Sulfonamides,
Macrolides,
Aminoglycosides,
Lincosamides,
Fluoroquinolones,
Cephalosporins and Other Antimicrobials and
Antibiotics

By Mode of Delivery

Premixes,
Oral Powder,
Oral Solution,
Injection and
Others

By Animal Type

Food-Producing Animals,
Companion Animals

Location

GEOGRAPHY

Frequently Asked Questions

The animal antibiotics and antimicrobials market is projected to expand at a CAGR of 4.2% during the forecast period.

The major players in the global animal antibiotics and antimicrobials market are Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK) and Kyoritsu Seiyaku (Japan).

North America is the fastest-growing region for animal antibiotics and antimicrobials market

Report

Table Of Content

1. Executive Summary

2. Global Animal Antibiotics and Antimicrobials Market Introduction

2.1. Global Animal Antibiotics and Antimicrobials Market – Taxonomy

2.2. Global Animal Antibiotics and Antimicrobials Market –Definitions

2.2.1. By Product Type

2.2.2. By Mode of Delivery

2.2.3. By Animal Type

2.2.4. By Region

3. Global Animal Antibiotics and Antimicrobials Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Animal Antibiotics and Antimicrobials Market Dynamic Factors – Impact Analysis

3.6. Global Animal Antibiotics and Antimicrobials Market – Competition Landscape

4. Global Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028

4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Animal Antibiotics and Antimicrobials Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1. Tetracyclines

5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Penicillins

5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Sulfonamides

5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

5.4. Macrolides

5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Aminoglycosides

5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

5.6. Lincosamides

5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.6.3. Market Opportunity Analysis

5.7. Fluoroquinolones

5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.7.3. Market Opportunity Analysis

5.8. Cephalosporins

5.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.8.3. Market Opportunity Analysis

5.9. Other Antimicrobials and Antibiotics

5.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.9.3. Market Opportunity Analysis

6. Global Animal Antibiotics and Antimicrobials Market, By Mode of Delivery, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.1. Premixes

6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Oral Powder

6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Oral Solution

6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Injection

6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Others

6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

7. Global Animal Antibiotics and Antimicrobials Market, By Animal Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.1. Food Processing Animals

7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Companion Animals

7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

8. Global Animal Antibiotics and Antimicrobials Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.1. North America

8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia-Pacific

8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Latin America

8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Middle East and Africa

8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Global Animal Antibiotics and Antimicrobials Market – Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Region, 2022-2028

9. North America Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Tetracyclines

9.1.2. Penicillins

9.1.3. Sulfonamides

9.1.4. Macrolides

9.1.5. Aminoglycosides

9.1.6. Lincosamides

9.1.7. Fluoroquinolones

9.1.8. Cephalosporins

9.1.9. Other Antimicrobials and Antibiotics

9.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.2.1. Premixes

9.2.2. Oral Powder

9.2.3. Oral Solution

9.2.4. Injection

9.2.5. Others

9.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.3.1. Food-Producing Animals

9.3.2. Companion Animals

9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.4.1. USA

9.4.2. Canada

9.5. North America Animal Antibiotics and Antimicrobials Market – Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028

9.6. North America Animal Antibiotics and Antimicrobials Market Dynamics – Trends

10. Europe Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

10.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Tetracyclines

10.1.2. Penicillins

10.1.3. Sulfonamides

10.1.4. Macrolides

10.1.5. Aminoglycosides

10.1.6. Lincosamides

10.1.7. Fluoroquinolones

10.1.8. Cephalosporins

10.1.9. Other Antimicrobials and Antibiotics

10.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Premixes

10.2.2. Oral Powder

10.2.3. Oral Solution

10.2.4. Injection

10.2.5. Others

10.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Food-Producing Animals

10.3.2. Companion Animals

10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. Germany

10.4.2. UK

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Russia

10.4.7. Rest of Europe

10.5. Europe Animal Antibiotics and Antimicrobials Market – Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028

10.6. Europe Animal Antibiotics and Antimicrobials Market Dynamics – Trends

11. Asia-Pacific Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

11.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Tetracyclines

11.1.2. Penicillins

11.1.3. Sulfonamides

11.1.4. Macrolides

11.1.5. Aminoglycosides

11.1.6. Lincosamides

11.1.7. Fluoroquinolones

11.1.8. Cephalosporins

11.1.9. Other Antimicrobials and Antibiotics

11.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Premixes

11.2.2. Oral Powder

11.2.3. Oral Solution

11.2.4. Injection

11.2.5. Others

11.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Food-Producing Animals

11.3.2. Companion Animals

11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.4.1. China

11.4.2. India

11.4.3. Japan

11.4.4. ASEAN

11.4.5. Australia & New Zealand

11.4.6. Rest of Asia-Pacific

11.5. Asia-Pacific Animal Antibiotics and Antimicrobials Market – Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028

11.6. Asia-Pacific Animal Antibiotics and Antimicrobials Market Dynamics – Trends

12. Latin America Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

12.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Tetracyclines

12.1.2. Penicillins

12.1.3. Sulfonamides

12.1.4. Macrolides

12.1.5. Aminoglycosides

12.1.6. Lincosamides

12.1.7. Fluoroquinolones

12.1.8. Cephalosporins

12.1.9. Other Antimicrobials and Antibiotics

12.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1. Premixes

12.2.2. Oral Powder

12.2.3. Oral Solution

12.2.4. Injection

12.2.5. Others

12.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. Food-Producing Animals

12.3.2. Companion Animals

12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Animal Antibiotics and Antimicrobials Market – Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028

12.6. Latin America Animal Antibiotics and Antimicrobials Market Dynamics – Trends

13. Middle East and Africa Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

13.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Tetracyclines

13.1.2. Penicillins

13.1.3. Sulfonamides

13.1.4. Macrolides

13.1.5. Aminoglycosides

13.1.6. Lincosamides

13.1.7. Fluoroquinolones

13.1.8. Cephalosporins

13.1.9. Other Antimicrobials and Antibiotics

13.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.2.1. Premixes

13.2.2. Oral Powder

13.2.3. Oral Solution

13.2.4. Injection

13.2.5. Others

13.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. Food-Producing Animals

13.3.2. Companion Animals

13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.4.1. Gulf Cooperation Council (GCC) Countries

13.4.2. South Africa

13.4.3. Rest of MEA

13.5. MEA Animal Antibiotics and Antimicrobials Market – Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028

13.6. MEA Animal Antibiotics and Antimicrobials Market Dynamics – Trends

14. Competition Landscape

14.1. Strategic Dashboard of Top Market Players

14.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)

14.2.1. Boehringer Ingelheim (Germany)

14.2.2. Zoetis Inc. (US)

14.2.3. Elanco Animal Health (US)

14.2.4. Merck & Co. Inc (US)

14.2.5. Phibro Animal Health (US)

14.2.6. Virbac (France)

14.2.7. Vetoquinol S.A. (France)

14.2.8. Ceva Santé Animale (France)

14.2.9. Dechra Pharmaceuticals Plc (UK)

14.2.10. Kyoritsu Seiyaku (Japan)

15. Research Methodology

16. Key Assumptions and Acronyms

Description
Reviews (0)

Description

Key Developments:

In Jul 2020, Zoetis collaborated with Trianni, Inc to build transgenic monoclonal antibody platforms to develop novel veterinary therapeutics.

Reviews

There are no reviews yet.

Be the first to review “Animal Antibiotics and Antimicrobials Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028”

search

Animal Antibiotics and Antimicrobials Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Description

Animal Antibiotics and Antimicrobials Market

Animal Antibiotics and Antimicrobials Market

Features of the Report

By Product Type

By Mode of Delivery

By Animal Type

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Reviews

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE